显微乳房再造住院时长演变:16年ACS-NSQIP 21777例皮瓣分析
基于ACS-NSQIP 2007-2022年21771例游离皮瓣乳房再造的回顾性分析,采用Poisson回归评估延长住院时长的预测因素。结果显示年均住院时长下降2.6%,总降幅31.25%(4.64天降至3.19天);手术时长每小时增加住院时长6.2%,糖尿病和出血性疾病分别增加5.8%和15.1%。
要点
- 2007-2022年游离皮瓣乳房再造住院时长年均下降2.6%,总体从4.64天降至3.19天。
- 手术时长每小时、糖尿病、出血性疾病、ASA II/III是延长住院时长的独立预测因素。
- 上述因素可用于风险分层和手术规划,以优化围手术期资源配置。
核心结论
- 2007至2022年游离皮瓣乳房再造住院时长显著下降,反映手术技术与围手术期管理的进步。
- 延长住院时长的关键预测因素包括手术时长、合并症和ASA分级。
研究设计与样本
- 回顾性分析ACS-NSQIP数据库2007-2022年数据,以CPT 19364识别游离皮瓣乳房再造病例。
- 共纳入21771例游离皮瓣再造,采用Poisson回归模型并经AIC引导的后向逐步选择建立最简模型。
- 报告发生率比(IRR)及95%置信区间(CI)。
主要发现
- 2007至2022年手术量逐年增加,平均住院时长下降31.25%,从4.64天降至3.19天。
- 每一年份与住院时长降低2.6%相关(IRR=0.974;95%CI:0.972-0.976)。
- 手术时长每增加1小时,住院时长增加6.2%(IRR=1.062;95%CI:1.060-1.065)。
- 糖尿病和出血性疾病分别使住院时长增加5.8%和15.1%。
- ASA II和III级较ASA I级分别与住院时长增加4.4%和8.5%相关。
临床怎么用
- 可利用手术时长、糖尿病、出血性疾病及ASA分级对游离皮瓣乳房再造患者进行住院时长风险分层。
- 针对高风险患者优化围手术期管理,可能有助于缩短住院时长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reducing postoperative length of stay (LoS) benefits both patients and hospi- tal systems. This study leverages the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to identify predictors of extended LoS following microsurgical free flap breast reconstruction. METHODS: We retrospectively analyzed NSQIP data (2007-2022) to identify factors influencing LoS after free flap reconstruction, using CPT code 19364 to identify cases. Candidate predictors were chosen based on clinical relevance and entered into a Poisson regression model. A backward stepwise selection approach, guided by Akaike's Information Criterion (AIC), was applied to derive the most parsimonious model. Incidence rate ratios (IRRs) with 95% confidence intervals (CIs) were reported. RESULTS: A total of 21,771 free flap reconstructions were analyzed. Procedure volume increased annually between 2007 and 2022, during which mean LoS decreased by 31.25%, from 4.64 to 3.19 days. Each year was associated with a 2.6% reduction in LoS (IRR = 0.974; 95% CI: 0.972-0.976). Longer operative time increased LoS by 6.2% per hour (IRR = 1.062; 95% CI: 1.060-1.065). Dia- betes and bleeding disorders increased LoS by 5.8% and 15.1%, respectively. ASA II and III were associated with 4.4% and 8.5% longer LoS vs ASA I. CONCLUSIONS: From 2007 to 2022, LoS for free flap breast reconstruction significantly declined, reflecting advancements in surgical techniques and perioperative care. Key predictors of extended LoS included operative time, comorbidities, and ASA classification. Findings provide valuable insights for risk stratification and surgical planning.
引用
- Karamitros G, Catic A, Grant MP, et al. Evolution of Length of Stay in Microsurgical Breast Reconstruction: A National Big Data Study of 21,777 Flap Cases from a 16-Year ACS-NSQIP Analysis. Plast Reconstr Surg. 2026. PMID: 41712273. doi:10.1097/PRS.0000000000012904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。